Quantcast
Saturday , August 19 2017
Breaking News
Home / Lahore / TUSKON offers free stalls to Pak businessmen at TWTB 2013
TUSKON offers free stalls to Pak businessmen at TWTB 2013

TUSKON offers free stalls to Pak businessmen at TWTB 2013

LAHORE: The Turkish Confederation of Businessmen and Industrialists (TUSKON) is offering the Pakistani businessmen free stalls at its world famous series of international business summits, Turkey World Trade Bridge (TWTB), on November 25-26, 2013 in Istanbul which will cover sectors of Food, Agriculture, and Fast Moving Consumer Goods, and Related Machinery.

TWTB 2013 possesses the most essential characteristics of trade bridge concept such as product exhibition, scheduled B2B meetings, historical and cultural tour of Istanbul, factory and company visits and optional business trips to different parts of Turkey.

This was revealed by Secretary General Pak-Turk Businessmen Association Taner Kocyigit while speaking at the Lahore Chamber of Commerce and Industry. LCCI President Engineer Sohail Lashari, Senior Vice President Mian Tariq Misbah, Vice President Kashif Anwar, Sahir Reshid, Chairman Pak-Turk Businessmen Association, former LCCI president Basher A Baksh were prominent among the speakers while Executive Committee Members Naseeb Ahamd Saifi and Haji Muhammad Akram were also present in the meeting.

The Secretary General Pak-Turk Businessmen Association said that TWTB 2013 is a golden opportunity for Pakistani businessmen because it would enable them to interact with their counterparts in Europe, Africa, Britain, Central Asia and SAARC countries.

It is of special significance to Pakistani businessmen in the sense that they would not be charged for participating in the exhibition while all other exhibitors including Turkish businessmen would have to pay 1000 Euros per stall per company. It would also be providing Pakistani businessmen a chance to exhibit their products to the whole world under one roof. The TWTB 2013 has been designed in a way that it would benefit the exhibitors to the maximum.